Prnewswireยท2025-06-27 23:57Group 1 - Halper Sadeh LLC is investigating potential violations of federal securities laws and breaches of fiduciary duties related to Carisma Therapeutics Inc.'s merger with OrthoCellix, Inc., where existing Carisma shareholders are expected to own approximately 10% of the combined company [1] - Enzo Biochem, Inc. is being sold to Battery Ventures for $0.70 per share in cash, while Guaranty Bancshares, Inc. is being sold to Glacier Bancorp, Inc. for 1.0000 share of Glacier stock for each Guaranty share [2] - Halper Sadeh LLC may seek increased consideration for shareholders and additional disclosures concerning the proposed transactions [3] Group 2 - Shareholders are encouraged to contact Halper Sadeh LLC to discuss their legal rights and options, with the firm representing investors globally who have experienced securities fraud and corporate misconduct [4]